Cargando…

NELSON lung cancer screening study

The Dutch-Belgian Randomized Lung Cancer Screening Trial (Dutch acronym: NELSON study) was designed to investigate whether screening for lung cancer by low-dose multidetector computed tomography (CT) in high-risk subjects will lead to a decrease in 10-year lung cancer mortality of at least 25% compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ying Ru, Xie, Xueqian, de Koning, Harry J, Mali, Willem P, Vliegenthart, Rozemarijn, Oudkerk, Matthijs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266562/
https://www.ncbi.nlm.nih.gov/pubmed/22185865
http://dx.doi.org/10.1102/1470-7330.2011.9020
_version_ 1782222188645974016
author Zhao, Ying Ru
Xie, Xueqian
de Koning, Harry J
Mali, Willem P
Vliegenthart, Rozemarijn
Oudkerk, Matthijs
author_facet Zhao, Ying Ru
Xie, Xueqian
de Koning, Harry J
Mali, Willem P
Vliegenthart, Rozemarijn
Oudkerk, Matthijs
author_sort Zhao, Ying Ru
collection PubMed
description The Dutch-Belgian Randomized Lung Cancer Screening Trial (Dutch acronym: NELSON study) was designed to investigate whether screening for lung cancer by low-dose multidetector computed tomography (CT) in high-risk subjects will lead to a decrease in 10-year lung cancer mortality of at least 25% compared with a control group without screening. Since the start of the NELSON study in 2003, 7557 participants underwent CT screening, with scan rounds in years 1, 2, 4 and 6. In the current review, the design of the NELSON study including participant selection and the lung nodule management protocol, as well as results on validation of CT screening and first results on lung cancer screening are described.
format Online
Article
Text
id pubmed-3266562
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-32665622013-10-03 NELSON lung cancer screening study Zhao, Ying Ru Xie, Xueqian de Koning, Harry J Mali, Willem P Vliegenthart, Rozemarijn Oudkerk, Matthijs Cancer Imaging Lung Cancer Screening The Dutch-Belgian Randomized Lung Cancer Screening Trial (Dutch acronym: NELSON study) was designed to investigate whether screening for lung cancer by low-dose multidetector computed tomography (CT) in high-risk subjects will lead to a decrease in 10-year lung cancer mortality of at least 25% compared with a control group without screening. Since the start of the NELSON study in 2003, 7557 participants underwent CT screening, with scan rounds in years 1, 2, 4 and 6. In the current review, the design of the NELSON study including participant selection and the lung nodule management protocol, as well as results on validation of CT screening and first results on lung cancer screening are described. e-Med 2011-10-03 /pmc/articles/PMC3266562/ /pubmed/22185865 http://dx.doi.org/10.1102/1470-7330.2011.9020 Text en © 2011 International Cancer Imaging Society
spellingShingle Lung Cancer Screening
Zhao, Ying Ru
Xie, Xueqian
de Koning, Harry J
Mali, Willem P
Vliegenthart, Rozemarijn
Oudkerk, Matthijs
NELSON lung cancer screening study
title NELSON lung cancer screening study
title_full NELSON lung cancer screening study
title_fullStr NELSON lung cancer screening study
title_full_unstemmed NELSON lung cancer screening study
title_short NELSON lung cancer screening study
title_sort nelson lung cancer screening study
topic Lung Cancer Screening
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266562/
https://www.ncbi.nlm.nih.gov/pubmed/22185865
http://dx.doi.org/10.1102/1470-7330.2011.9020
work_keys_str_mv AT zhaoyingru nelsonlungcancerscreeningstudy
AT xiexueqian nelsonlungcancerscreeningstudy
AT dekoningharryj nelsonlungcancerscreeningstudy
AT maliwillemp nelsonlungcancerscreeningstudy
AT vliegenthartrozemarijn nelsonlungcancerscreeningstudy
AT oudkerkmatthijs nelsonlungcancerscreeningstudy